PIPELINE

Research & Development

Oncology

Oncology

Oncology

Dermatology

Ophthalmology

SB01,SB02

Anti-Angiogenesis Tumor Drug

SB05 PC

EndoTAG®-1Pancreatic Cancer

SB05 TNBC

EndoTAG®-1Triple-Negative Breast Cancer

SB03

Veregen®External Genital Warts

SB04

Age-Related Macular Degeneration

SynCore Biotechnology

Professional, Innovation, and Respect of life

We are a global, new drug developing biopharmaceutical company provide only evidence-based medicine.Established in 2008, SynCore was cofounded by Sinphar Group and National Health Research Institute (NHRI) Taiwan. We focus on creating values of new drug by R&D management and integration of technology resources. SynCore’s pipeline concentrates on oncology, ophthalmology, and dermatology fields, continuously dedicates in helping patients worldwide.